A new clinical trial will compare the use of Carthera’s SonoCloud-9 implantable ultrasound device plus chemotherapy to standard-of-care therapies in patients with glioblastoma.
The study will enroll 560 participants at 40 sites throughout the US and Europe.
As Executive Director, Bob Smith will oversee Foundation activities related to the gene therapy, cancer immunotherapy, veterinary medicine, neurodegenerative diseases, and FUS Partners programs.
Mr. Smith was formerly senior vice president of the Global Gene Therapy Business at Pfizer, Inc.
In a recent radio interview, John shared his story of undergoing focused ultrasound to treat the symptoms of his Parkinson’s disease.
The 3-minute segment also features Foundation Chairman Neal F. Kassell, MD, discussing how the technology could impact many more areas of medicine, including cancer.
The International OCD Foundation is offering $500,000 in research funding through two grant types related to advancing treatment of obsessive-compulsive disorder (OCD).
“There has been considerable research at the University of Virginia and now Virginia Tech. We are positioning the entire Commonwealth of Virginia on the leading edge of high-tech development in focused ultrasound.”
‒ Neal F. Kassell, MD, in Virginia Public Radio Interview
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
By using FUSF’s AI agent, you acknowledge and agree that your use is governed by FUSF’s Terms of Use Agreement. If you do not agree to be bound by the Terms of Use Agreement, you may not access or use FUSF’s AI agent.
